Comparison of Prognostic Significance of Amino-Terminal Pro-Brain Natriuretic Peptide Versus Blood Urea Nitrogen for Predicting Events in Patients Hospitalized for Heart Failure

American Journal of Cardiology

Volumn 99, Issue 8, 2007, Pages 1143-1145

  Shenkman, Heather J ^a   Zareba, Wojciech ^a   Bisognano, John D ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HEART FAILURE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD UREA NITROGEN; CARDIAC OUTPUT, LOW; CREATININE; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PATIENT ADMISSION; PATIENT READMISSION; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS;

EID: 34147122767     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.11.050     Document Type: Article

References (8)

1. Doust J.A., Pietrzak E., Dobson A., and Glasziou P.P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 (2005) 625-633
2. Bayes-Genis A., Lopez L., Zapico E., Cotes C., Santalo M., Ordonez-Llanos J., and Cinca J. NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality. J Cardiac Fail 11 suppl (2005) S3-S8
3. Heywood J.T., Elatre W., Pai R.G., Fabbri S., and Huiskes B. Simple clinical criteria to determine the prognosis of heart failure. J Cardiovasc Pharmacol Ther 10 (2005) 173-180
4. Aronson D., Mittleman M.A., and Burger A.J. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 116 (2004) 466-473
5. Tsutamoto T., Wada A., Sakai H., Ishikawa C., Tanaka T., Hayashi M., Fujii M., Yamamoto T., Dohke T., Ohnishi M., et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 47 (2006) 583-586
6. Logeart D., Thabut G., Jourdain P., Chavelas C., Beyne P., Beauvais F., Bouvier E., and Cohen Solal A. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 (2004) 635-641
7. Feola M., Aspromonte N., Canali C., Ceci V., Giovinazzo P., Milani L., Quarta G., Ricci R., Scardovi A.B., Uslenghi E., and Valle R. Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure. Am J Cardiol 96 (2005) 705-709
8. Januzzi Jr. J.L., Sakhuja R., O'Donoghue M., Baggish A.L., Anwaruddin S., Chae C.U., Cameron R., Krauser D.G., Tung R., Camargo Jr. C.A., and Lloyd-Jones D.M. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Int Med 166 (2006) 315-320